Enhanced glucagon-like peptide-1 (GLP-1) secretion leads to rapid improvement of glucose tolerance and insulin secretion after laparoscopic sleeve gastrectomy (LSG)

被引:0
|
作者
Kusunoki, Chisato [1 ]
Ugi, Satoshi [1 ]
Yamamoto, Hiroshi [2 ]
Kamo, Azusa [1 ]
Hashimoto, Tetsuya [1 ]
Nishio, Yoshihiko [1 ]
Kasama, Kazunori [3 ]
Tani, Toru [2 ]
Kashiwagi, Atsunori [1 ]
Maegawa, Hiroshi [1 ]
机构
[1] Shiga Univ Med Sci, Dept Med, Shiga, Japan
[2] Shiga Univ Med Sci, Dept Surg, Shiga, Japan
[3] Yotsuya Medicalcube Hosp, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S433 / S433
页数:1
相关论文
共 50 条
  • [31] Glucagon-like peptide-1 (GLP-1) secretion is decreased in type II diabetic patients compared to matched control subjects with normal glucose tolerance
    Toft-Nielsen, MB
    Damholt, MB
    Hilsted, L
    Hughes, T
    Krarup, T
    Madsbad, S
    Holst, JJ
    DIABETES, 1999, 48 : A22 - A22
  • [32] The human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS
    Wheeler, MB
    Leng, XH
    Ligon, BB
    Boyd, AE
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE ISLETS OF LANGERHANS, 1997, 426 : 113 - 119
  • [33] THE COLON AS A SOURCE FOR GLUCAGON-LIKE PEPTIDE-1 (GLP-1)
    HOLST, JJ
    OLESEN, KM
    GUDMANDHOYER, E
    DEACON, CF
    HANSEN, CP
    JOHNSEN, AH
    MIHOLIC, J
    NAUCK, M
    QUALMANN, C
    DIABETOLOGIA, 1995, 38 : A170 - A170
  • [34] Pulsatile secretion of glucagon-like peptide-1(GLP-1) from pancreatic alpha cells: evidence for independent mechanism from intestinal GLP-1 secretion in rodents
    Nakashima, K.
    Hamamoto, S.
    Kimura, Y.
    Shimoda, M.
    Tawaramoto, K.
    Hirukawa, H.
    Kimura, T.
    Okauchi, S.
    Kaku, K.
    DIABETOLOGIA, 2013, 56 : S25 - S25
  • [35] The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: No evidence for a role of glucagon-like peptide-1 (GLP-1)
    Svartberg, J
    Holst, JJ
    Gutniak, M
    Adner, N
    PANCREAS, 1998, 16 (01) : 66 - 71
  • [36] Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
    Nauck, M. A.
    Vardarli, I.
    Deacon, C. F.
    Holst, J. J.
    Meier, J. J.
    DIABETOLOGIA, 2011, 54 (01) : 10 - 18
  • [37] Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
    M. A. Nauck
    I. Vardarli
    C. F. Deacon
    J. J. Holst
    J. J. Meier
    Diabetologia, 2011, 54 : 10 - 18
  • [38] Novel TGR5 agonists stimulating biosynthesis and secretion of glucagon-like peptide-1 (GLP-1)
    Jafri, L.
    Saleem, S.
    Calderwood, D.
    Gillespie, A.
    Mirza, B.
    Green, B. D.
    DIABETIC MEDICINE, 2016, 33 : 26 - 27
  • [39] Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects
    Valverde, I
    Puente, J
    Martín-Duce, A
    Molina, L
    Lozano, O
    Sancho, V
    Malaisse, WJ
    Villanueva-Peñacarrillo, ML
    OBESITY SURGERY, 2005, 15 (03) : 387 - 397
  • [40] Glucagon-like peptide-1: Regulation of insulin secretion and therapeutic potential
    Gromada, J
    Brock, B
    Schmitz, O
    Rorsman, P
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 95 (06) : 252 - 262